Back to Results
First PageMeta Content
Antivirals / Pharmacology / Pyrazines / Telaprevir / Boceprevir / Pharmaceutical Benefits Scheme / Hepatitis C / Interferon / Ribavirin / Medicine / Health / Protease inhibitors


NEW HEPATITIS C ANTIVIRAL DRUGS Date: Tuesday 25 February 2014 Time: 1.30 am – 4.30 pm Venue: Sirius Building, Furzer St Woden, Canberra
Add to Reading List

Document Date: 2014-10-01 21:56:29

Open Document

File Size: 45,45 KB

Share Result on Facebook

City

Canberra / /

Country

Australia / /

Facility

St Vincent’s hospital / Sirius Building / /

IndustryTerm

clinical treatment algorithm / tertiary healthcare clinics / healthcare system / HCV therapies / cost products / healthcare centres / patient support network / /

MedicalCondition

advanced disease / CHC / HIV / Disease / total hepatitis C / cirrhosis / hepatitis C / HCV / rash side effects / CHC infection / infection / hepatitis / rash / HIV disease / fibrosis / /

MedicalTreatment

oral therapies / /

Organization

Pharmaceutical Benefits Advisory Committee / St Vincent’s hospital in Melbourne / Department of Human Services / Medical Services Advisory Committee / US Food & Drug Administration / /

Person

Suzanne Hill / Alicia Segrave / Paul Desmond / /

Position

Professor / Chair / General / Secretary / /

Product

ribavirin / peginterferon / /

Technology

clinical treatment algorithm / genotyping / genotype / /

SocialTag